ReVision Optics, Inc.

ReVision Optics is focused on developing optical solutions to treat presbyopia, the loss of near vision that is associated with aging. ReVision Optics has developed Raindrop® Near Vision Inlay, a simple solution that helps reduce or eliminate the need for reading glasses. Raindrop® is bioengineered to be the world's first inlay to change the shape of the cornea. Raindrop® has been available globally for several years, and received FDA approval in the US in June of 2016.SUMMARY OF IMPORTANT INFORMATIONThe Raindrop Near Vision Inlay may not eliminate the need for reading glasses.Implantation of the Raindrop Near Vision Inlay has the potential to cause vision and eye symptoms; dry eyes; decreased vision; decreased contrast sensitivity; problems with the cornea, such as clouding, thinning, scarring, and inflammation; eye infection; increased eye pressure; and the need for another eye surgery, such as removal or replacement of the inlay, or other treatment.You should not have the Raindrop Near Vision Inlay implanted if you have severe dry eye; have an active eye infection or active inflammation; have signs of corneal disease characterized by general thinning and cone-shaped protrusion in the center of the cornea (keratoconus) or keratoconus suspect; have abnormal features of the outer part of the eye (cornea) to be implanted; have active abnormal immune response (autoimmune) or connective tissue diseases; do not have enough corneal thickness to safely have the procedure performed; have a recent herpes eye infection or problems resulting from a previous infection; have uncontrolled buildup of high pressure in the eye (glaucoma); have uncontrolled high blood sugar (diabetes).Before having the Raindrop Near Vision Inlay procedure you should have a complete eye examination and talk with your eye care provider about alternative treatments, potential benefits, complications, risks, healing time, and any other concerns you have about having the procedure.